Psychiatric adverse events associated with GLP-1 receptor agonists: a real-world pharmacovigilance study based on the FDA Adverse Event Reporting System database
The levels of GLP-1 in joint fluid closely mirrored those found in the bloodstream
After 30 min, dogs (5 per group) were administered with either: IntelliCap capsules (Medimetrics, Eindhoven, Netherlands) filled with 0.7 mL of peptide and permeation enhancer solution (J229 8 mg/mL, NaCDC 12 mg/mL)
Its active ingredient, tirzepatide, is also approved for weight loss under the brand name Zepbound
Liraglutide ameliorates renal injury in streptozotocininduced diabetic rats by activating endothelial nitric oxide synthase activity via the downregulation of the nuclear factor-B pathway
Dispose of used needles in an FDA-approved sharps container, never in regular trash or down the toilet